UBS Group AG - ITERUM THERAPEUTICS PLC ownership

ITERUM THERAPEUTICS PLC's ticker is ITRM and the CUSIP is G6333L101. A total of 42 filers reported holding ITERUM THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ITERUM THERAPEUTICS PLC
ValueSharesWeighting
Q2 2022$0
-100.0%
1
-100.0%
0.00%
Q1 2022$10,000
-60.0%
29,485
-54.6%
0.00%
Q4 2021$25,000
+257.1%
65,006
+437.9%
0.00%
Q3 2021$7,000
-89.7%
12,085
-58.7%
0.00%
Q2 2021$68,000
-9.3%
29,233
-44.8%
0.00%
Q1 2021$75,000
+120.6%
52,961
+324.0%
0.00%
Q1 2020$34,000
+277.8%
12,492
+542.3%
0.00%
Q4 2019$9,000
-43.8%
1,945
-28.6%
0.00%
Q3 2019$16,0002,724
+5241.2%
0.00%
Q2 2019$0
-100.0%
51
-61.4%
0.00%
Q4 2018$1,0001320.00%
Other shareholders
ITERUM THERAPEUTICS PLC shareholders Q3 2021
NameSharesValueWeighting ↓
Canaan Partners X LLC 1,733,170$346,0000.60%
New Leaf Venture Partners, L.L.C. 1,456,303$292,0000.19%
GSA CAPITAL PARTNERS LLP 304,684$61,0000.01%
Krilogy Financial LLC 200,000$40,0000.01%
Focused Wealth Management, Inc 105,000$21,0000.00%
Virtu Financial LLC 110,470$22,0000.00%
GRIMES & COMPANY, INC. 179,396$36,0000.00%
IFP Advisors, Inc 6,000$72,0000.00%
Principle Wealth Partners LLC 30,000$6,0000.00%
OSAIC HOLDINGS, INC. 1,280$00.00%
View complete list of ITERUM THERAPEUTICS PLC shareholders